These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 15380717)

  • 1. Application of liquid chromatography/mass spectrometry and nuclear magnetic resonance to the identification of degradates of a novel insulin sensitizer in aqueous solutions.
    Wang MH; Wu Y; Hwang TL; Qin XZ; Karki S; Treemaneekarn V
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Oct; 810(2):209-19. PubMed ID: 15380717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of oxidative degradates of the TRIS salt of a 5,6,7,8-tetrahydro-1,8-naphthyridine derivative by LC/MS/MS and NMR spectroscopy--interactions between the active pharmaceutical ingredient and its counterion.
    Wu Y; Hwang TL; Algayer K; Xu W; Wang H; Procopio A; DeBusi L; Yang CY; Matuszewska B
    J Pharm Biomed Anal; 2003 Dec; 33(5):999-1015. PubMed ID: 14656591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of losartan degradates in stressed tablets by LC-MS and LC-MS/MS.
    Zhao Z; Wang Q; Tsai EW; Qin XZ; Ip D
    J Pharm Biomed Anal; 1999 Jun; 20(1-2):129-36. PubMed ID: 10704016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of degradation products of diclofenac by electrospray ion trap mass spectrometry.
    Galmier MJ; Bouchon B; Madelmont JC; Mercier F; Pilotaz F; Lartigue C
    J Pharm Biomed Anal; 2005 Jul; 38(4):790-6. PubMed ID: 15967311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification by LC/MS(n) of degradates of a novel carbapenem antibiotic in an aqueous matrix.
    Zhao ZZ; Qin XZ; Reed RA
    J Pharm Biomed Anal; 2002 Jun; 29(1-2):173-81. PubMed ID: 12062676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural identification of nonvolatile dimerization products of glucosamine by gas chromatography-mass spectrometry, liquid chromatography-mass spectrometry, and nuclear magnetic resonance analysis.
    Jun M; Shao Y; Ho CT; Koetter U; Lech S
    J Agric Food Chem; 2003 Oct; 51(21):6340-6. PubMed ID: 14518965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Forced degradation and impurity profiling: recent trends in analytical perspectives.
    Jain D; Basniwal PK
    J Pharm Biomed Anal; 2013 Dec; 86():11-35. PubMed ID: 23969330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Critical practical aspects in the application of liquid chromatography-mass spectrometric studies for the characterization of impurities and degradation products.
    Narayanam M; Handa T; Sharma P; Jhajra S; Muthe PK; Dappili PK; Shah RP; Singh S
    J Pharm Biomed Anal; 2014 Jan; 87():191-217. PubMed ID: 23706957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of oxidative degradates of the thrombin inhibitor, 3-(2-phenethylamino)-6-methyl-1-(2-amino-6-methyl-5-methyleneca rboxamidomethylpyridinyl)pyrazinone, using liquid chromatography/mass spectrometry and liquid chromatography/tandem mass spectrometry.
    Wu Y; Chen X; Gier L; Almarsson O; Ostovic D; Loper AE
    J Pharm Biomed Anal; 1999 Jul; 20(3):471-85. PubMed ID: 10701963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The stability of biapenem and structural identification of impurities in aqueous solution.
    Xia M; Hang TJ; Zhang F; Li XM; Xu XY
    J Pharm Biomed Anal; 2009 May; 49(4):937-44. PubMed ID: 19278804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification, isolation and characterization of potential degradation products in pioglitazone hydrochloride drug substance.
    Ramulu K; Kumar TT; Krishna SR; Vasudev R; Kaviraj M; Rao BM; Rao NS
    Pharmazie; 2010 Mar; 65(3):162-8. PubMed ID: 20383934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Photosensitized degradation of losartan potassium in an extemporaneous suspension formulation.
    Seburg RA; Ballard JM; Hwang TL; Sullivan CM
    J Pharm Biomed Anal; 2006 Oct; 42(4):411-22. PubMed ID: 16787732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study of the forced degradation behavior of prasugrel hydrochloride by liquid chromatography with mass spectrometry and liquid chromatography with NMR detection and prediction of the toxicity of the characterized degradation products.
    Singh DK; Sahu A; Handa T; Narayanam M; Singh S
    J Sep Sci; 2015 Sep; 38(17):2995-3005. PubMed ID: 26114771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanistic study of the oxidative degradation of the triazole antifungal agent CS-758 in an amorphous form.
    Ueyama E; Suzuki N; Kano K
    J Pharm Sci; 2013 Jan; 102(1):104-13. PubMed ID: 23042572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidative degradation studies of an oxazolidinone-derived antibacterial agent, RWJ416457, in aqueous solutions.
    Dong J; Karki SB; Parikh M; Riggs JC; Huang L
    Drug Dev Ind Pharm; 2012 Nov; 38(11):1289-97. PubMed ID: 22263626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmaceutical application of LC-MS. 1--Characterization of a famotidine degradate in a package screening study by LC-APCI MS.
    Qin XZ; Ip DP; Chang KH; Dradransky PM; Brooks MA; Sakuma T
    J Pharm Biomed Anal; 1994 Feb; 12(2):221-33. PubMed ID: 8003549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-performance liquid chromatography quadrupole time-of-flight mass spectrometry method for the analysis of antidiabetic drugs in aqueous environmental samples.
    Martín J; Buchberger W; Santos JL; Alonso E; Aparicio I
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 May; 895-896():94-101. PubMed ID: 22483984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liquid chromatography/mass spectrometry (LC/MS) identification of photooxidative degradates of crystalline and amorphous MK-912.
    Qin X; Frech P
    J Pharm Sci; 2001 Jul; 90(7):833-44. PubMed ID: 11458333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of LC-MS/TOF, LC-MS(n), NMR and LC-NMR in characterization of stress degradation products: Application to cilazapril.
    Narayanam M; Sahu A; Singh S
    J Pharm Biomed Anal; 2015; 111():190-203. PubMed ID: 25890215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New degradation product of spiradoline mesylate in aqueous solution: formation of an imidazolidine ring.
    Ogata M; Shimizu R; Abe H
    J Pharm Sci; 1993 Jan; 82(1):91-4. PubMed ID: 8429499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.